دوره 8، شماره 4 - ( 4-1396 )
جلد 8 شماره 4 صفحات 238-228 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saburi E, Saburi A, Ghanei M. Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside . Caspian J Intern Med 2017; 8 (4) :228-238
URL: http://caspjim.com/article-1-847-fa.html
URL: http://caspjim.com/article-1-847-fa.html
Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside . . 1396; 8 (4) :228-238
چکیده: (10564 مشاهده)
Immunotherapy has been used for years in many types of cancer therapy. Recently, cancer immunotherapy has focused on mechanisms which can enhance the development of cell-mediated immunity. Anticancer medications are administered to inhibit immunosuppressive factors such as nagalase enzyme, which is produced by neoplastic cells and destroys macrophage activating factor (Gc-MAF). Anti-neoplastics medications can also enhance immune-cell activity against tumors. Such medications show great potential in cancer immunotherapy using natural human mechanisms against neoplasms.
نوع مطالعه: Review Article |
موضوع مقاله:
Oncology
دریافت: 1395/6/1 | پذیرش: 1395/12/16 | انتشار: 1396/5/7
دریافت: 1395/6/1 | پذیرش: 1395/12/16 | انتشار: 1396/5/7
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
